Inventor
VANHUIS CHAD A
US15 patents
⚠️ This page may combine multiple inventors who share the name “VANHUIS CHAD A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LYCERA CORP
9 patentsUS9896441B2Feb 20, 2018
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
LYCERA CORP6 citations83
US10442798B2Oct 15, 2019
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
LYCERA CORP2 citations72
US10364237B2Jul 30, 2019
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
LYCERA CORP2 citations72
US9580388B2Feb 28, 2017
Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
LYCERA CORP4 citations72
US10611740B2Apr 7, 2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
LYCERA CORP1 citations61
US10421751B2Sep 24, 2019
Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
LYCERA CORP2 citations61
US9932313B2Apr 3, 2018
Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
LYCERA CORP1 citations51
US9815791B2Nov 14, 2017
Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
LYCERA CORP1 citations50
US10556898B2Feb 11, 2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
LYCERA CORP0 citations40
MERCK SHARP & DOHME
5 patentsUS10221146B2Mar 5, 2019
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations83
US9809561B2Nov 7, 2017
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME8 citations83
US9783511B2Oct 10, 2017
Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME9 citations83
US9663502B2May 30, 2017
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME12 citations82
US10745364B2Aug 18, 2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME0 citations51